Data search
Results for MligTC455_24992
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_24992 | 222 | 4.62 | Mlig455_040423 | Neo: - Age: Up-Down-Down |
PTPRD | Mlig455_040423 {REF} {Length: 5511} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=536.0]; Fibronectin type III domain [PF00041.23, score=69.6]; Tyrosine phosphatase family [PF13350.8, score=37.9]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=33.7]; Inositol hexakisphosphate [PF14566.8, score=24.3]} {Human: ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [RH, Score=1010, Expect=0.0]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [RH, Score=1009, Expect=0.0]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [RH, Score=1023, Expect=0.0]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [RH, Score=1011, Expect=0.0]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [RH, Score=1004, Expect=0.0]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [RH, Score=928, Expect=0.0]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_10176_0_2, dd_Smed_v6_10176_0_2, [RH, Score=962, Expect=0.0]} {RNA1509_45823, RNA1509_59220} {RNA1310_2694.1, RNA1509_45823, RNA1509_59220} {RNA1509_45823, RNA1509_59220, RNA815_2245.1} |
Cumulative graph for MligTC455_24992
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.106 | 2.729 | 0.96316 | 1.00000 | |
| RegionR2 | 1.224 | 2.729 | 0.12099 | 0.43062 | |
| RegionR3 | -0.135 | 2.729 | 0.87121 | 1.00000 | |
| RegionR4 | -0.588 | 2.729 | 0.55570 | 0.87578 | |
| RegionR5 | -1.104 | 2.729 | 0.17666 | 0.45089 | |
| RegionR6 | 1.153 | 2.729 | 0.07979 | 0.52143 | |
| RegionR7 | 1.246 | 2.729 | 0.11717 | 0.64670 | |
| RegionR8 | -1.69 | 2.729 | 0.32149 | 0.95564 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.53 | 2.729 | 0.86172 | 1.00000 | |
| RegenerationR2 | -0.404 | 2.729 | 0.49040 | 0.86770 | |
| RegenerationR3 | 0.019 | 2.729 | 0.99320 | 1.00000 | |
| RegenerationR4 | -1.68 | 2.729 | 0.08809 | 0.46578 | |
| RegenerationR5 | 0.208 | 2.729 | 0.80064 | 0.98882 | |
| RegenerationR6 | -1.133 | 2.729 | 0.10729 | 0.40537 | |
| RegenerationBL | -2.282 | 2.729 | 0.11576 | 0.40260 | |
| RegenerationTP | -0.153 | 2.729 | 0.91879 | 1.00000 |
Genes with expression patterns similar to MligTC455_24992
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_24992 | 222 | 4.62 | Mlig455_040423 | Neo: - Age: Up-Down-Down |
PTPRD | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_040423 {REF} {Length: 5511} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=536.0]; Fibronectin type III domain [PF00041.23, score=69.6]; Tyrosine phosphatase family [PF13350.8, score=37.9]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=33.7]; Inositol hexakisphosphate [PF14566.8, score=24.3]} {Human: ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [RH, Score=1010, Expect=0.0]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [RH, Score=1009, Expect=0.0]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [RH, Score=1023, Expect=0.0]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [RH, Score=1011, Expect=0.0]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [RH, Score=1004, Expect=0.0]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [RH, Score=928, Expect=0.0]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_10176_0_2, dd_Smed_v6_10176_0_2, [RH, Score=962, Expect=0.0]} {RNA1509_45823, RNA1509_59220} {RNA1310_2694.1, RNA1509_45823, RNA1509_59220} {RNA1509_45823, RNA1509_59220, RNA815_2245.1} |
| 2. | MligTC455_24993 | 233 | 4.86 | Mlig455_050468 | Neo: - Age: Up-Down-Down |
PTPRS | 5.956 | 0.996 | 0.992 | 0.987 | 0.997 | 0.995 | 0.989 | Mlig455_050468 {REF} {Length: 2099} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=259.3]; Tyrosine phosphatase family [PF13350.8, score=26.7]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=20.1]} {Human: ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [Score=499, Expect=3e-164]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [Score=494, Expect=1e-163]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [Score=500, Expect=7e-167]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [Score=493, Expect=2e-162]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [Score=491, Expect=9e-163]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [Score=454, Expect=7e-146]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [Score=318, Expect=9e-100]} {Smed: dd_Smed_v6_9734_0_1, dd_Smed_v6_9734_0_1, [Score=439, Expect=8e-146]} {RNA1509_59220} {RNA1310_403.1} {RNA815_2245.3} |
| 3. | MligTC455_40011 | 150 | 3.12 | Mlig455_004436, Mlig455_004448 | Neo: - |
3.399 | 0.883 | 0.755 | - | 0.803 | 0.958 | - | Mlig455_004436 {REF} {Length: 595} {RNA1310_81676} Mlig455_004448 {REF} {Length: 1192} {RNA1310_81676} |
|
| 4. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 2.722 | - | 0.849 | - | 0.964 | 0.909 | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
| 5. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
2.688 | - | 0.843 | - | 0.969 | 0.876 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
| 6. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
2.668 | - | 0.791 | - | 0.911 | 0.966 | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
| 7. | MligTC455_26832 | 211 | 4.39 | Mlig455_000690 | Neo: - Age: Down-Up-Down |
ANK3 | 2.619 | - | 0.776 | - | 0.889 | 0.954 | - | Mlig455_000690 {REF} {Length: 2225} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=184.0]; Ankyrin repeats (many copies) [PF13637.8, score=128.0]; Ankyrin repeat [PF00023.32, score=96.2]; Ankyrin repeats (many copies) [PF13857.8, score=94.5]; Ankyrin repeat [PF13606.8, score=92.4]; SOCS box [PF07525.18, score=29.0]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=120, Expect=6e-28]; ENSG00000135299, ANKRD6, ankyrin repeat domain 6, [Score=119, Expect=7e-28]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=122, Expect=1e-28]; ENSMUSG00000040183, Ankrd6, ankyrin repeat domain 6, [Score=122, Expect=6e-29]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=121, Expect=1e-28]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=97.4, Expect=6e-21]} {Smed: dd_Smed_v6_17293_0_1, dd_Smed_v6_17293_0_1, [RH, Score=549, Expect=0.0]} {RNA1509_43489} {RNA1310_16486.1} {RNA815_13229} |
| 8. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
2.604 | - | 0.733 | - | 0.921 | 0.950 | - | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
| 9. | MligTC455_37683 | 97 | 2.03 | Mlig455_027754 | Neo: - Age: - |
KCNN2 | 2.594 | - | 0.794 | - | 0.831 | 0.969 | - | Mlig455_027754 {REF} {Length: 1617} {Pfam: Calmodulin binding domain [PF02888.18, score=117.1]; Ion channel [PF07885.18, score=49.9]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=359, Expect=1e-120]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=353, Expect=1e-120]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=343, Expect=4e-115]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=358, Expect=1e-120]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=353, Expect=2e-116]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=400, Expect=1e-137]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=303, Expect=2e-98]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [Score=355, Expect=1e-118]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_9828.1} |
| 10. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 2.59 | - | 0.772 | - | 0.855 | 0.963 | - | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
| 11. | MligTC455_28903 | 55 | 1.14 | Mlig455_030222, Mlig455_067999 | Neo: - Age: Up-Down-Down |
FAT4 | 2.578 | - | 0.837 | - | 0.969 | 0.772 | - | Mlig455_030222 {REF} {Length: 8676} {Pfam: Cadherin domain [PF00028.19, score=744.0]; Cadherin-like [PF16184.7, score=94.9]; Cadherin-like [PF08266.14, score=40.7]; RET Cadherin like domain 1 [PF17756.3, score=23.4]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=518, Expect=1e-147]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=9e-152]} {Dmel: FBgn0001075, ft, fat, [Score=479, Expect=9e-136]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=260, Expect=4e-69]} {RNA1509_58830} {RNA1310_15141, RNA1509_58830} {RNA1509_58830, RNA815_18357} Mlig455_067999 {REF} {Length: 8147} {Pfam: Cadherin domain [PF00028.19, score=745.9]; Cadherin-like [PF16184.7, score=94.8]; Cadherin-like [PF08266.14, score=40.9]; RET Cadherin like domain 1 [PF17756.3, score=23.3]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=519, Expect=6e-148]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=7e-152]} {Dmel: FBgn0001075, ft, fat, [Score=476, Expect=8e-135]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=261, Expect=2e-69]} {RNA1509_58830} {RNA1310_15141} {RNA815_18357} |
| 12. | MligTC455_19819 | 67 | 1.39 | Mlig455_042327, Mlig455_047107 | Neo: - Age: - |
2.576 | - | 0.842 | - | 0.969 | 0.765 | - | Mlig455_042327 {REF} {Length: 1414} {RNA1310_83687} Mlig455_047107 {REF} {Length: 1283} {RNA1310_83687} |
|
| 13. | MligTC455_46517 | 122 | 2.54 | Mlig455_051299 | Neo: - Age: - Region-enriched R2: 3.450/0.03846 |
ERC2 | 2.559 | - | 0.774 | - | 0.961 | 0.824 | - | Mlig455_051299 {REF} {Length: 6303} {TRANSSPLICED} {Pfam: RIM-binding protein of the cytomatrix active zone [PF10174.11, score=167.4]; Tropomyosin like [PF12718.9, score=22.2]; Autophagy protein 16 (ATG16) [PF08614.13, score=20.7]} {Human: ENSG00000187672, ERC2, ELKS/RAB6-interacting/CAST family member 2, [Score=143, Expect=1e-33]} {Mouse: ENSMUSG00000040640, Erc2, ELKS/RAB6-interacting/CAST family member 2, [Score=143, Expect=6e-34]} {Dmel: FBgn0259246, brp, bruchpilot, [Score=117, Expect=1e-25]} {Smed: dd_Smed_v6_12278_0_1, dd_Smed_v6_12278_0_1, [Score=211, Expect=9e-55]} {RNA1509_45174, RNA1509_45537} {RNA1310_5220.1, RNA1509_45537} {RNA1509_45537, RNA815_13350} |
| 14. | MligTC455_29516 | 38 | 0.8 | Mlig455_029373 | Neo: - Age: Up-Down-Up |
GRIA2 | 2.55 | - | - | 0.772 | 0.963 | 0.815 | - | Mlig455_029373 {REF} {Length: 3044} {Pfam: Ligand-gated ion channel [PF00060.28, score=103.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=63.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=23.4]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=158, Expect=3e-39]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=158, Expect=3e-39]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=157, Expect=5e-39]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=155, Expect=2e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=155, Expect=3e-38]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=154, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=153, Expect=1e-37]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=159, Expect=2e-39]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=158, Expect=2e-39]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=155, Expect=2e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=155, Expect=1e-38]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=153, Expect=1e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=152, Expect=1e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=152, Expect=3e-37]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=152, Expect=3e-37]} {Dmel: FBgn0038837, CG3822, [Score=151, Expect=3e-37]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=139, Expect=1e-33]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=241, Expect=1e-71]} {RNA1310_63010} {RNA815_33834} |
| 15. | MligTC455_28483 | 912 | 19 | Mlig455_056019 | Neo: - Age: - Region-enriched R2: 1.652/0.01432 |
XPO4 | 2.51 | 0.728 | - | - | 0.978 | 0.804 | - | Mlig455_056019 {REF} {Length: 4372} {TRANSSPLICED} {Human: ENSG00000132953, XPO4, exportin 4, [RH, Score=241, Expect=2e-64]} {Mouse: ENSMUSG00000021952, Xpo4, exportin 4, [RH, Score=241, Expect=7e-65]} {Smed: dd_Smed_v6_10330_0_1, dd_Smed_v6_10330_0_1, [RH, Score=72.4, Expect=1e-12]} {RNA1509_11967, RNA1509_55558} {RNA1310_2509.1, RNA1509_55558} {RNA1509_55558, RNA815_8640} |
| 16. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.505 | - | 0.759 | - | 0.952 | 0.794 | - | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
| 17. | MligTC455_25056 | 93 | 1.94 | Mlig455_049698, Mlig455_049704 | Neo: - Age: - Region-enriched R2: 5.783/0.00015 |
2.487 | - | 0.807 | - | 0.958 | 0.722 | - | Mlig455_049698 {REF} {Length: 2094} {Smed: dd_Smed_v6_10049_0_1, dd_Smed_v6_10049_0_1, [Score=104, Expect=1e-23]} {RNA1310_40293} {RNA815_29568} Mlig455_049704 {REF} {Length: 2512} {RNA1509_20101} {RNA1310_40293} {RNA815_29568} |
|
| 18. | MligTC455_48273 | 617 | 12.85 | Mlig455_022862 | Neo: - Age: - Region-specific R2: 3.800 Region-enriched R2: 2.763/0.00002 |
2.414 | - | - | - | 0.957 | 0.727 | 0.730 | Mlig455_022862 {REF} {Length: 691} {RNA1509_20965, RNA1509_21383} {RNA1310_55481, RNA1509_20965, RNA1509_21383} {RNA1509_20965, RNA1509_21383, RNA815_28392} | |
| 19. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
1.917 | - | - | - | 0.976 | 0.941 | - | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} | |
| 20. | MligTC455_50255 | 777 | 16.18 | Mlig455_018293 | Neo: - Age: Down-Up-Up Region-enriched R2: 1.926/0.01583 |
1.904 | - | - | - | 0.971 | 0.933 | - | Mlig455_018293 {REF} {Length: 691} {Smed: dd_Smed_v6_8966_0_1, dd_Smed_v6_8966_0_1, [RH, Score=70.9, Expect=1e-16]} {RNA1509_37352} {RNA1310_62086} {RNA815_22267.2} | |
| 21. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
1.902 | - | - | - | 0.948 | 0.954 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
| 22. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
1.901 | - | - | - | 0.973 | 0.928 | - | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
| 23. | MligTC455_16866 | 18 | 0.37 | Mlig455_065296 | Neo: - Age: - |
1.9 | - | - | - | 0.965 | 0.935 | - | Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472} | |
| 24. | MligTC455_16867 | 18 | 0.37 | Mlig455_065319 | Neo: - Age: - |
1.9 | - | - | - | 0.965 | 0.935 | - | Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472} | |
| 25. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
1.896 | - | - | - | 0.934 | 0.962 | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
| 26. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
1.89 | - | - | - | 0.924 | 0.966 | - | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
| 27. | MligTC455_41180 | 128 | 2.66 | Mlig455_048529 | Neo: - Age: - Region-enriched R2: 3.286/0.00629 |
1.888 | 0.909 | - | - | - | 0.979 | - | Mlig455_048529 {REF} {Length: 672} {NoTransDecoderORF} {RNA1310_69878} {RNA815_35715} | |
| 28. | MligTC455_17039 | 24 | 0.5 | Mlig455_025016 | Neo: - Age: - |
1.886 | - | - | - | 0.965 | 0.921 | - | Mlig455_025016 {REF} {Length: 2009} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.8]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [RH, Score=209, Expect=1e-63]} {RNA1310_42205} {RNA815_15017} | |
| 29. | MligTC455_45080 | 3677 | 76.61 | Mlig455_021478, Mlig455_062024, Mlig455_063226, Mlig455_067363 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.291 Region-enriched R8: 1.930/0.00003 |
1.882 | - | - | - | 0.964 | 0.918 | - | Mlig455_021478 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_062024 {REF} {Length: 752} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_063226 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_067363 {REF} {Length: 767} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} |
|
| 30. | MligTC455_40649 | 24 | 0.49 | Mlig455_066232 | Neo: - Age: - |
1.881 | - | - | - | 0.915 | 0.966 | - | Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590} | |
| 31. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 1.88 | - | - | - | 0.969 | 0.911 | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
| 32. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
1.874 | - | - | - | 0.954 | 0.920 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
| 33. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
1.871 | - | - | - | 0.963 | 0.908 | - | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
| 34. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
1.87 | - | - | - | 0.975 | 0.895 | - | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
| 35. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 1.866 | - | - | - | 0.910 | 0.956 | - | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
| 36. | MligTC455_48523 | 615 | 12.81 | Mlig455_027573 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.661 Region-enriched R2: 5.785/0.00008 |
1.863 | - | - | - | 0.958 | 0.905 | - | Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574} | |
| 37. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 1.862 | - | - | - | 0.910 | 0.952 | - | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
| 38. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
1.859 | - | - | - | 0.966 | 0.893 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
| 39. | MligTC455_38279 | 69 | 1.44 | Mlig455_045200 | Neo: - Age: - |
NOL4L | 1.858 | 0.907 | - | - | - | 0.951 | - | Mlig455_045200 {REF} {Length: 1997} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=150, Expect=9e-40]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=150, Expect=1e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=147, Expect=2e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1310_76365.1} {RNA815_48196} |
| 40. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
1.858 | - | - | - | 0.962 | 0.896 | - | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
| 41. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
1.857 | - | - | - | 0.952 | 0.905 | - | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
| 42. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.847 | - | - | - | 0.953 | 0.894 | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
| 43. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
1.841 | - | - | - | 0.875 | 0.966 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
| 44. | MligTC455_16166 | 638 | 13.28 | Mlig455_045546, Mlig455_052637 | Neo: - Age: - |
B3GALT5 | 1.836 | - | - | - | 0.958 | 0.878 | - | Mlig455_045546 {REF} {Length: 2520} {Pfam: Galactosyltransferase [PF01762.23, score=159.0]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=113, Expect=5e-27]; ENSMUSG00000074892, B3galt5, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5, [Score=111, Expect=2e-26]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=110, Expect=1e-25]} {Dmel: FBgn0035558, CG11357, [RH, Score=147, Expect=3e-38]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=72.8, Expect=3e-14]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=149, Expect=5e-40]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} Mlig455_052637 {REF} {Length: 2225} {Pfam: Galactosyltransferase [PF01762.23, score=159.1]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=114, Expect=1e-27]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=109, Expect=3e-25]} {Dmel: FBgn0035558, CG11357, [Score=143, Expect=1e-36]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=71.2, Expect=3e-13]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=152, Expect=3e-41]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} |
| 45. | MligTC455_43889 | 8 | 0.16 | Mlig455_042755 | Neo: - |
GRM8 | 1.833 | - | - | - | 0.970 | 0.863 | - | Mlig455_042755 {REF} {Length: 4300} {Pfam: Receptor family ligand binding region [PF01094.30, score=260.1]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=174.7]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=45.9]; Periplasmic binding protein [PF13458.8, score=31.1]} {Human: ENSG00000179603, GRM8, glutamate metabotropic receptor 8, [RH, Score=714, Expect=0.0]; ENSG00000196277, GRM7, glutamate metabotropic receptor 7, [RH, Score=709, Expect=0.0]; ENSG00000124493, GRM4, glutamate metabotropic receptor 4, [RH, Score=683, Expect=0.0]} {Mouse: ENSMUSG00000024211, Grm8, glutamate receptor, metabotropic 8, [RH, Score=711, Expect=0.0]; ENSMUSG00000056755, Grm7, glutamate receptor, metabotropic 7, [RH, Score=707, Expect=0.0]; ENSMUSG00000063239, Grm4, glutamate receptor, metabotropic 4, [RH, Score=694, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=652, Expect=0.0]} {Celegans: WBGene00021152, mgl-3, Metabotropic GLutamate receptor family, [RH, Score=622, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [Score=600, Expect=0.0]} {RNA1310_30380} {RNA815_34532} |
| 46. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 1.833 | - | - | - | 0.960 | 0.873 | - | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
| 47. | MligTC455_51790 | 524 | 10.92 | Mlig455_012435, Mlig455_012564 | Neo: - Age: - Region-enriched R2: 2.233/0.04465 Regeneration-downregulated BL: -4.065 Regeneration-depleted BL: -4.065 |
PRKAR2A | 1.832 | - | - | - | 0.970 | 0.862 | - | Mlig455_012435 {REF} {Length: 1982} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=139.6]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=50.9]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [RH, Score=380, Expect=6e-130]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [RH, Score=397, Expect=6e-137]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [RH, Score=407, Expect=4e-141]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=216, Expect=1e-66]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [RH, Score=457, Expect=2e-161]} {RNA1509_20187} {RNA1310_20991} {RNA815_24093} Mlig455_012564 {REF} {Length: 1980} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=139.6]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=50.9]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [RH, Score=380, Expect=6e-130]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [RH, Score=397, Expect=6e-137]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [RH, Score=407, Expect=4e-141]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=216, Expect=1e-66]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [RH, Score=457, Expect=2e-161]} {RNA1509_20187} {RNA1310_20991} {RNA815_24093} |
| 48. | MligTC455_45880 | 278 | 5.8 | Mlig455_051498 | Neo: - Age: - Region-enriched R2: 5.081/0.00218 |
CALM2 | 1.831 | - | 0.870 | - | - | 0.961 | - | Mlig455_051498 {REF} {Length: 2328} {Pfam: EF-hand domain pair [PF13499.8, score=48.0]; EF-hand domain [PF14658.8, score=32.2]; EF-hand domain [PF13405.8, score=23.0]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=84.0, Expect=1e-20]; ENSG00000160014, CALM3, calmodulin 3, [Score=84.0, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=84.0, Expect=1e-20]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=84.0, Expect=9e-21]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=84.0, Expect=9e-21]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=84.0, Expect=9e-21]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.8, Expect=2e-20]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.8, Expect=1e-20]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=82.8, Expect=9e-21]} {RNA1509_41430} {RNA1310_44424} {RNA815_28870} |
| 49. | MligTC455_47259 | 985 | 20.52 | Mlig455_024978 | Neo: - Age: - Region-enriched R2: 2.522/0.00122 |
1.83 | - | - | - | 0.970 | 0.860 | - | Mlig455_024978 {REF} {Length: 514} {RNA1310_63739.2} {RNA815_33907} | |
| 50. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 1.824 | - | - | - | 0.957 | 0.867 | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
| 51. | MligTC455_48358 | 291 | 6.07 | Mlig455_009342, Mlig455_036996 | Neo: - Age: - Region-specific R2: 6.920 Region-enriched R2: 5.581/0.00062 |
FOXA2 | 1.819 | - | 0.867 | - | - | 0.952 | - | Mlig455_009342 {REF} {Length: 3571} {Pfam: Forkhead domain [PF00250.20, score=129.1]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [RH, Score=237, Expect=2e-71]; ENSG00000129514, FOXA1, forkhead box A1, [RH, Score=231, Expect=3e-69]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [RH, Score=243, Expect=5e-74]; ENSMUSG00000035451, Foxa1, forkhead box A1, [RH, Score=231, Expect=2e-69]} {Dmel: FBgn0000659, fkh, fork head, [RH, Score=245, Expect=1e-72]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [RH, Score=204, Expect=6e-59]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [RH, Score=246, Expect=3e-75]} {RNA1509_57651} {RNA1310_8486.1} {RNA815_24959.1} Mlig455_036996 {REF} {Length: 3801} {Pfam: Forkhead domain [PF00250.20, score=129.0]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [RH, Score=237, Expect=1e-71]; ENSG00000129514, FOXA1, forkhead box A1, [RH, Score=231, Expect=3e-69]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [RH, Score=243, Expect=5e-74]; ENSMUSG00000035451, Foxa1, forkhead box A1, [RH, Score=231, Expect=2e-69]} {Dmel: FBgn0000659, fkh, fork head, [RH, Score=245, Expect=1e-72]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [RH, Score=204, Expect=7e-59]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [RH, Score=246, Expect=3e-75]} {RNA1509_57651} {RNA1310_8486.1, RNA1509_57651} {RNA1509_57651, RNA815_24959.1} |
| 52. | MligTC455_19252 | 1355 | 28.24 | Mlig455_054908, Mlig455_065614, Mlig455_065623 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.927/0.00706 |
QPCT | 1.806 | 0.971 | - | - | - | 0.835 | - | Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475} Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784} Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475} |
| 53. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 1.803 | - | - | - | 0.956 | 0.847 | - | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
| 54. | MligTC455_46470 | 552 | 11.5 | Mlig455_066293 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.795/0.00284 |
1.802 | - | - | - | 0.975 | 0.827 | - | Mlig455_066293 {REF} {Length: 896} {RNA1509_9692} {RNA1310_57568} {RNA815_29793} | |
| 55. | MligTC455_48160 | 12 | 0.25 | Mlig455_059561 | Neo: - Age: - |
1.8 | - | 0.843 | - | 0.957 | - | - | Mlig455_059561 {REF} {Length: 1191} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=27.9]} {RNA1310_31078} {RNA815_45415} | |
| 56. | MligTC455_36153 | 63 | 1.31 | Mlig455_068201 | Neo: - Age: Up-Down-Down |
ZFYVE9 | 1.798 | - | - | - | 0.973 | 0.825 | - | Mlig455_068201 {REF} {Length: 2852} {Pfam: Domain of unknown function (DUF3480) [PF11979.10, score=106.6]} {Human: ENSG00000157077, ZFYVE9, zinc finger FYVE-type containing 9, [Score=132, Expect=5e-32]} {Mouse: ENSMUSG00000034557, Zfyve9, zinc finger, FYVE domain containing 9, [Score=134, Expect=7e-33]} {Dmel: FBgn0026369, Sara, Smad anchor for receptor activation, [Score=122, Expect=6e-29]} {Celegans: WBGene00000101, aka-1, A Kinase Anchor protein; A kinase anchor protein, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_8098_0_1, dd_Smed_v6_8098_0_1, [Score=82.4, Expect=2e-16]} {RNA1509_39700} {RNA1310_6234.1} {RNA815_2939.1} |
| 57. | MligTC455_45314 | 24 | 0.5 | Mlig455_043345 | Neo: - Age: - |
1.788 | - | 0.827 | - | 0.961 | - | - | Mlig455_043345 {REF} {Length: 1422} {Pfam: Pancreatic hormone peptide [PF00159.20, score=27.9]} {RNA1310_91502} {RNA815_61453} | |
| 58. | MligTC455_40782 | 1513 | 31.52 | Mlig455_021202 | Neo: - Age: Up-Down-Up Region-specific R2: 2.950 Region-enriched R2: 1.950/0.00004 Regeneration-downregulated BL: -2.428 Regeneration-depleted BL: -2.428 |
1.787 | - | - | - | 0.956 | 0.831 | - | Mlig455_021202 {REF} {Length: 2276} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} | |
| 59. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
1.783 | - | - | - | 0.964 | 0.819 | - | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
| 60. | MligTC455_44329 | 510 | 10.62 | Mlig455_026184, Mlig455_026199 | Neo: - Age: - Region-specific R2: 5.127 Region-enriched R2: 4.824/0.00000 |
1.782 | - | - | - | 0.978 | 0.804 | - | Mlig455_026184 {REF} {Length: 724} {RNA1509_29216, RNA1509_32102} {RNA1310_60068, RNA1509_29216} {RNA1509_29216, RNA815_37486} Mlig455_026199 {REF} {Length: 531} {RNA1509_32102} {RNA1310_60068} {RNA815_37486} |
|
| 61. | MligTC455_02244 | 25 | 0.53 | Mlig455_026007, Mlig455_070432 | Neo: - Age: - |
1.781 | 0.831 | - | - | 0.950 | - | - | Mlig455_026007 {REF} {Length: 604} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [Score=91.3, Expect=3e-24]} {RNA1310_143494} Mlig455_070432 {REF} {Length: 1561} {Dmel: FBgn0050419, CG30419, [RH, Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [RH, Score=112, Expect=2e-32]} {RNA1310_143494} |
|
| 62. | MligTC455_15805 | 9 | 0.19 | Mlig455_023117 | Neo: - Age: - |
KCNK18 | 1.781 | - | 0.816 | - | 0.965 | - | - | Mlig455_023117 {REF} {Length: 1703} {Pfam: Ion channel [PF07885.18, score=119.1]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=101, Expect=6e-23]; ENSG00000100433, KCNK10, potassium two pore domain channel subfamily K member 10, [Score=96.3, Expect=1e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=103, Expect=7e-24]} {Dmel: FBgn0085425, CG34396, [Score=155, Expect=3e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=155, Expect=1e-42]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=338, Expect=1e-112]} {RNA1310_118169} |
| 63. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
1.779 | - | - | - | 0.822 | 0.957 | - | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
| 64. | MligTC455_40874 | 65 | 1.34 | Mlig455_051048 | Neo: - Age: - |
ASIC5 | 1.777 | - | 0.810 | - | 0.967 | - | - | Mlig455_051048 {REF} {Length: 2313} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=194.4]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=54.3, Expect=4e-07]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=64.7, Expect=1e-10]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [RH, Score=491, Expect=1e-167]} {RNA1509_56048} {RNA1310_34335} {RNA815_62672} |
| 65. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 1.774 | - | - | - | 0.969 | 0.805 | - | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
| 66. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1.763 | - | - | - | 0.969 | 0.794 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
| 67. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 1.756 | - | - | - | 0.971 | 0.785 | - | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
| 68. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 1.752 | - | - | - | 0.967 | 0.785 | - | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
| 69. | MligTC455_07586 | 302 | 6.29 | Mlig455_059282, Mlig455_065216 | Neo: - Age: - |
CHRNA7 | 1.751 | 0.977 | - | - | 0.774 | - | - | Mlig455_059282 {REF} {Length: 3061} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=212.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=132.3]; Protein of unknown function (DUF812) [PF05667.13, score=20.1]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=281, Expect=5e-87]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=281, Expect=5e-87]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=277, Expect=1e-85]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=275, Expect=3e-85]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=271, Expect=9e-82]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=271, Expect=1e-83]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=268, Expect=3e-82]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=281, Expect=2e-87]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=276, Expect=1e-85]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=272, Expect=2e-84]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=268, Expect=2e-82]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=268, Expect=1e-80]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=294, Expect=1e-91]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=259, Expect=4e-79]} {Smed: dd_Smed_v6_6939_0_3, dd_Smed_v6_6939_0_3, [Score=564, Expect=0.0]} {RNA1509_48605} {RNA1310_10796.1} {RNA815_3826.1} Mlig455_065216 {REF} {Length: 2934} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=212.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=132.4]; Protein of unknown function (DUF812) [PF05667.13, score=21.2]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=283, Expect=9e-88]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=281, Expect=2e-87]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=278, Expect=7e-86]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=276, Expect=6e-86]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=271, Expect=7e-82]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=271, Expect=8e-84]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=269, Expect=2e-82]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=281, Expect=1e-87]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=276, Expect=8e-86]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=271, Expect=2e-84]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=270, Expect=4e-83]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=267, Expect=9e-81]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=295, Expect=4e-92]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=260, Expect=8e-80]} {Smed: dd_Smed_v6_6939_0_1, dd_Smed_v6_6939_0_1, [RH, Score=568, Expect=0.0]} {RNA1509_48605} {RNA1310_10796.1} {RNA815_3826.1} |
| 70. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 1.747 | - | - | - | 0.962 | 0.785 | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
| 71. | MligTC455_41137 | 263 | 5.48 | Mlig455_019407 | Neo: - Age: - Region-enriched R2: 2.988/0.01472 |
GNG7 | 1.747 | - | - | - | 0.951 | - | 0.796 | Mlig455_019407 {REF} {Length: 752} {Pfam: GGL domain [PF00631.24, score=51.3]} {Human: ENSG00000176533, GNG7, G protein subunit gamma 7, [Score=49.7, Expect=3e-09]} {Mouse: ENSMUSG00000036402, Gng12, guanine nucleotide binding protein (G protein), gamma 12, [Score=48.5, Expect=6e-09]; ENSMUSG00000032766, Gng11, guanine nucleotide binding protein (G protein), gamma 11, [Score=47.0, Expect=2e-08]} {Dmel: FBgn0263029, CG43324, [Score=52.8, Expect=8e-11]} {Celegans: WBGene00001681, gpc-1, Guanine nucleotide-binding protein subunit gamma, [Score=50.8, Expect=3e-10]} {Smed: dd_Smed_v6_1237_0_2, dd_Smed_v6_1237_0_2, [Score=100, Expect=4e-30]} {RNA1509_49315} {RNA1310_60760.1} {RNA815_37265} |
| 72. | MligTC455_40063 | 1170 | 24.37 | Mlig455_005633, Mlig455_005677, Mlig455_008693 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.272 Region-specific R2: 8.260 Region-enriched R2: 8.105/0.00000 |
MAGEL2, TRO | 1.746 | - | - | - | 0.960 | 0.786 | - | Mlig455_005633 {REF} {Length: 2008} {Pfam: PMG protein [PF05287.14, score=47.1]} {Human: ENSG00000067445, TRO, trophinin, [Score=65.1, Expect=1e-10]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} Mlig455_005677 {REF} {Length: 1823} {Human: ENSG00000254585, MAGEL2, MAGE family member L2, [RH, Score=67.8, Expect=1e-12]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} Mlig455_008693 {REF} {Length: 1327} {Pfam: PMG protein [PF05287.14, score=30.5]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} |
| 73. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
1.745 | - | - | - | 0.977 | 0.768 | - | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
| 74. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
1.74 | - | - | - | 0.958 | 0.782 | - | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
| 75. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
1.734 | - | - | - | 0.767 | 0.967 | - | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
| 76. | MligTC455_08774 | 25 | 0.53 | Mlig455_001889 | Neo: - Age: Up-Down-Down |
HCRTR2 | 1.731 | 0.776 | - | - | - | 0.955 | - | Mlig455_001889 {REF} {Length: 3436} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=160.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=24.1]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=215, Expect=2e-63]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [RH, Score=212, Expect=1e-62]} {Dmel: FBgn0038874, ETHR, [Score=142, Expect=6e-37]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=116, Expect=6e-28]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=202, Expect=1e-59]} {RNA1310_31833} {RNA815_15909} |
| 77. | MligTC455_51764 | 938 | 19.55 | Mlig455_016061 | Neo: - Age: - Region-specific R2: 2.881 Region-enriched R2: 1.672/0.00180 |
1.731 | - | - | - | 0.973 | 0.758 | - | Mlig455_016061 {REF} {Length: 649} {RNA1509_58232} {RNA1310_60107.1, RNA1509_58232} {RNA1509_58232, RNA815_31573} | |
| 78. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 1.725 | - | - | - | 0.962 | 0.763 | - | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
| 79. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
1.721 | - | - | - | 0.973 | 0.748 | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
| 80. | MligTC455_25323 | 440 | 9.16 | Mlig455_044300 | Neo: - Age: - |
1.716 | - | - | - | - | 0.954 | 0.762 | Mlig455_044300 {REF} {Length: 4648} {Pfam: DDE superfamily endonuclease [PF13358.8, score=47.2]} {Dmel: FBgn0263076, Klp54D, Kinesin-like protein at 54D, [Score=76.6, Expect=7e-14]} {Smed: dd_Smed_v6_15852_0_1, dd_Smed_v6_15852_0_1, [Score=106, Expect=1e-24]} {RNA1509_56341} {RNA1310_5922.1} {RNA815_12097} | |
| 81. | MligTC455_41824 | 194 | 4.03 | Mlig455_048229 | Neo: - Age: - Region-enriched R2: 3.040/0.03860 |
1.714 | - | 0.735 | - | 0.979 | - | - | Mlig455_048229 {REF} {Length: 769} {RNA1509_49797} {RNA1310_60350, RNA1509_49797} {RNA1509_49797, RNA815_30999} | |
| 82. | MligTC455_39632 | 71 | 1.48 | Mlig455_039338 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.404/0.02299 |
APBA1 | 1.699 | - | 0.746 | - | - | 0.953 | - | Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653} |
| 83. | MligTC455_41968 | 247 | 5.15 | Mlig455_048152 | Neo: - Age: - Region-specific R2: 5.996 Region-enriched R2: 5.206/0.00199 |
1.698 | - | - | - | 0.967 | 0.731 | - | Mlig455_048152 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.6]} {RNA1509_40628} {RNA1310_50753} {RNA815_21607} | |
| 84. | MligTC455_16209 | 72 | 1.51 | Mlig455_020329 | Neo: - Age: - Region-enriched R2: 5.444/0.00658 |
1.696 | - | - | - | 0.737 | 0.959 | - | Mlig455_020329 {REF} {Length: 2483} {Pfam: TIR domain [PF13676.8, score=38.4]; TIR domain [PF01582.22, score=29.5]; Domain of unknown function (DUF4481) [PF14800.8, score=20.4]} {Dmel: FBgn0032095, Toll-4, [RH, Score=53.1, Expect=7e-07]} {Smed: dd_Smed_v6_14454_0_1, dd_Smed_v6_14454_0_1, [RH, Score=270, Expect=2e-82]} {RNA1310_32445} {RNA815_27719} | |
| 85. | MligTC455_47779 | 196 | 4.09 | Mlig455_018651 | Neo: - Age: Down-Down-Up Region-enriched R2: 5.953/0.04766 |
1.695 | 0.725 | - | - | 0.970 | - | - | Mlig455_018651 {REF} {Length: 521} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} | |
| 86. | MligTC455_12388 | 25 | 0.52 | Mlig455_000936 | Neo: - Age: - |
SETMAR | 1.694 | - | - | - | 0.953 | 0.741 | - | Mlig455_000936 {REF} {Length: 2242} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.4]; DDE superfamily endonuclease [PF13358.8, score=29.0]; Homeodomain-like domain [PF13565.8, score=24.2]; Transposase [PF01498.20, score=21.1]; Winged helix-turn helix [PF13551.8, score=19.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=167, Expect=3e-45]} {Smed: dd_Smed_v6_52102_0_1, dd_Smed_v6_52102_0_1, [Score=69.7, Expect=1e-14]} {RNA1310_28836.1} {RNA815_34045} |
| 87. | MligTC455_42700 | 851 | 17.73 | Mlig455_034472 | Neo: - Age: - Region-enriched R2: 1.255/0.04544 |
YWHAE | 1.687 | - | - | - | 0.725 | 0.962 | - | Mlig455_034472 {REF} {Length: 1614} {TRANSSPLICED} {Pfam: 14-3-3 protein [PF00244.22, score=258.7]} {Human: ENSG00000108953, YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, [Score=300, Expect=1e-103]; ENSG00000274474, YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, [Score=300, Expect=1e-103]} {Mouse: ENSMUSG00000020849, Ywhae, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide, [Score=300, Expect=1e-103]} {Dmel: FBgn0020238, 14-3-3epsilon, [Score=299, Expect=3e-103]} {Celegans: WBGene00001502, ftt-2, 14-3-3-like protein 2, [Score=236, Expect=8e-79]} {Smed: dd_Smed_v6_1702_0_1, dd_Smed_v6_1702_0_1, [Score=273, Expect=4e-93]} {RNA1509_35947, RNA1509_43335, RNA1509_50818} {RNA1310_15023.1, RNA1509_35947, RNA1509_50818} {RNA1509_35947, RNA1509_50818, RNA815_5579} |
| 88. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 1.686 | - | - | 0.724 | 0.962 | - | - | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
| 89. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 1.683 | - | - | - | 0.955 | 0.728 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
| 90. | MligTC455_25313 | 529 | 11.03 | Mlig455_047806, Mlig455_047883 | Neo: - Age: Up-Down-Down |
PCLO | 1.675 | - | - | - | 0.951 | 0.724 | - | Mlig455_047806 {REF} {Length: 4640} {Pfam: C2 domain [PF00168.32, score=102.8]; PDZ domain [PF17820.3, score=23.7]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=117, Expect=4e-26]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [Score=83.2, Expect=4e-16]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=7e-15]} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=198, Expect=2e-52]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} Mlig455_047883 {REF} {Length: 3110} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=192, Expect=2e-55]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} |
| 91. | MligTC455_33287 | 444 | 9.24 | Mlig455_061811 | Neo: - Age: - Region-enriched R2: 4.031/0.00004 |
1.674 | - | - | - | 0.965 | 0.709 | - | Mlig455_061811 {REF} {Length: 782} {RNA1509_48963} {RNA1310_53012} {RNA815_23468} | |
| 92. | MligTC455_29201 | 1280 | 26.67 | Mlig455_049817 | Neo: - Age: - Regeneration-downregulated BL: -1.729 Regeneration-depleted BL: -1.729 |
OTOF | 1.673 | - | - | - | 0.719 | 0.954 | - | Mlig455_049817 {REF} {Length: 7973} {Pfam: C2 domain [PF00168.32, score=225.3]; FerB (NUC096) domain [PF08150.14, score=99.1]; Ferlin C-terminus [PF16165.7, score=97.7]; FerI (NUC094) domain [PF08151.14, score=61.5]} {Human: ENSG00000115155, OTOF, otoferlin, [RH, Score=910, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [RH, Score=915, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [RH, Score=301, Expect=4e-84]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=150, Expect=9e-36]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1476, Expect=0.0]} {RNA1509_5256} {RNA1310_1416.2} {RNA815_411.1} |
| 93. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
1.671 | - | - | - | 0.961 | 0.710 | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
| 94. | MligTC455_27677 | 2582 | 53.78 | Mlig455_051394 | Neo: - Age: Down-Up-Up Region-specific R2: 3.156 Region-enriched R2: 2.518/0.00000 |
0.986 | - | - | - | 0.986 | - | - | Mlig455_051394 {REF} {Length: 690} {RNA1509_11612, RNA1509_32723, RNA1509_32853} {RNA1310_59474, RNA1509_11612, RNA1509_32723, RNA1509_32853} {RNA1509_11612, RNA1509_32723, RNA1509_32853, RNA815_28024} | |
| 95. | MligTC455_21812 | 20 | 0.42 | Mlig455_019683 | Neo: - Age: - |
NMUR2 | 0.974 | - | - | - | 0.974 | - | - | Mlig455_019683 {REF} {Length: 2876} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=22.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=22.5]; Olfactory receptor [PF13853.8, score=21.0]} {Human: ENSG00000132911, NMUR2, neuromedin U receptor 2, [RH, Score=172, Expect=2e-48]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [RH, Score=173, Expect=4e-49]} {Dmel: FBgn0037100, CapaR, Capability receptor, [RH, Score=210, Expect=1e-62]} {Celegans: WBGene00019616, nmur-2, NMUR (NeuroMedin U Receptor) homolog, [RH, Score=209, Expect=4e-63]} {Smed: dd_Smed_v6_17801_0_1, dd_Smed_v6_17801_0_1, [RH, Score=257, Expect=1e-81]} {RNA1310_96825} |
| 96. | MligTC455_14719 | 15 | 0.3 | Mlig455_010945 | Neo: - Age: - |
0.97 | - | - | - | 0.970 | - | - | Mlig455_010945 {REF} {Length: 2374} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=152.7]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [RH, Score=206, Expect=4e-59]} {RNA1310_23517.2} {RNA815_11158} | |
| 97. | MligTC455_48043 | 1751 | 36.48 | Mlig455_017279, Mlig455_017291 | Neo: - Age: - Region-enriched R7: 2.553/0.00000 Regeneration-downregulated BL: -2.231 Regeneration-depleted BL: -2.231 |
0.97 | - | - | - | - | 0.970 | - | Mlig455_017279 {REF} {Length: 4223} {RNA1509_52225} {RNA1310_3440.1} {RNA815_638.1} Mlig455_017291 {REF} {Length: 3855} {RNA1509_3814, RNA1509_50356} {RNA1310_3440.1, RNA1509_50356} {RNA1509_50356, RNA815_638.1} |
|
| 98. | MligTC455_18492 | 32 | 0.68 | Mlig455_026506 | Neo: - Age: - |
ADRA1B | 0.968 | - | - | - | - | 0.968 | - | Mlig455_026506 {REF} {Length: 1747} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=271.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=40.7]} {Human: ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=244, Expect=8e-74]} {Mouse: ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=242, Expect=3e-73]} {Dmel: FBgn0266137, Dop1R2, Dopamine 1-like receptor 2, [RH, Score=310, Expect=2e-96]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_22802_0_1, dd_Smed_v6_22802_0_1, [RH, Score=325, Expect=9e-107]} {RNA1310_108893} |
| 99. | MligTC455_02258 | 14 | 0.29 | Mlig455_004819, Mlig455_004888, Mlig455_004900 | Neo: - Age: - |
SLC9B2 | 0.967 | - | - | - | 0.967 | - | - | Mlig455_004819 {REF} {Length: 2596} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=54.1]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=125, Expect=5e-31]; ENSG00000164037, SLC9B1, solute carrier family 9 member B1, [Score=119, Expect=4e-29]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [Score=128, Expect=4e-32]; ENSMUSG00000037994, Slc9b2, solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2, [Score=128, Expect=3e-32]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [Score=115, Expect=1e-27]} {Celegans: WBGene00009618, F41E7.2, [Score=52.8, Expect=3e-07]} {Smed: dd_Smed_v6_7736_0_1, dd_Smed_v6_7736_0_1, [Score=126, Expect=1e-33]} {RNA1310_33802} Mlig455_004888 {REF} {Length: 2402} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=115.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=325, Expect=5e-102]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=326, Expect=6e-102]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=289, Expect=1e-86]} {Celegans: WBGene00009618, F41E7.2, [Score=138, Expect=3e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=361, Expect=1e-116]} {RNA1310_33802} Mlig455_004900 {REF} {Length: 3013} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=115.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=325, Expect=6e-102]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=326, Expect=5e-102]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=289, Expect=2e-86]} {Celegans: WBGene00009618, F41E7.2, [Score=139, Expect=2e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=361, Expect=2e-116]} {RNA1509_37253} {RNA1310_95649} {RNA815_29346.1} |
| 100. | MligTC455_51687 | 18 | 0.38 | Mlig455_046694 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_046694 {REF} {Length: 1039} {RNA1310_45984} |
There are 41 more genes with r >= 0.95